Evidence map›Paper›PMID 30347770›Full record

ArticleInternational journal of molecular sciences2018

PSMA-Oriented Target Delivery of Novel Anticancer Prodrugs: Design, Synthesis, and Biological Evaluations of Oligopeptide-Camptothecin Conjugates.

Bing Xu, Fei Zhou, Meng-Meng Yan, De-Sheng Cai, Wen-Bo Guo, Yu-Qin Yang, Xiao-Hui Jia, Wen-Xi Zhang, Tong Li, Tao Ma and 2 more

Open access · goldAbstract read
In one paragraph

Article in International journal of molecular sciences, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
0.5field-weighted citation impact, top 36% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 10 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 1 institution in 1 country.

Bing XuSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. weichenxubing@126.com.
Fei ZhouSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. zf116318@163.com.
Meng-Meng YanSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. yanmengmeng@bucm.edu.cn.
De-Sheng CaiSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. cai1225366978@163.com.
Wen-Bo GuoSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. wb_guo@126.com.
Yu-Qin YangSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. yangyq5@163.com.
Xiao-Hui JiaSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. 18811508665@163.com.
Wen-Xi ZhangSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. zhangwxnn@126.com.
Tong LiSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. lt1755258545@163.com.
Tao MaSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. mosesmatao@163.com.
Peng-Long WangSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. wpl581@126.com.
Hai-Min LeiSchool of Chinese Pharmacy, Beijing University of Chinese Medicine, Beijing 100102, China. hm_lei@126.com.ORCID 0000-0001-6765-9545
Beijing University of Chinese Medicine · CN

Funding

Beijing Key Laboratory for Basic and Development Research on Chinese Medicine 2017the National Natural Science Foundation of China 81173519the National Natural Science Foundation of China 81603256Young Teachers' Scientific Research Project of Beijing University of Chinese Medicine 2015-JYB JSMS023
6 · The paper itself

Abstract

Clinical applications of camptothecin (

Indexed as

Antigens, SurfaceAntineoplastic AgentsApoptosisCamptothecinGlutamate Carboxypeptidase IIHeLa CellsHep G2 CellsHumansMCF-7 CellsOligopeptidesProdrugsQuantitative Structure-Activity RelationshipAntigens, SurfaceAntineoplastic AgentsCamptothecinFOLH1 protein, humanGlutamate Carboxypeptidase IIOligopeptidesProdrugsapoptosiscamptothecinoligopeptide derivativesprostate-specific membrane antigenstructure-activity relationships

Identifiers

PMID30347770
PMCPMC6214026
OpenAlexW2895887350

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.